Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14
J Karhukorpi1, Y Yan, S Niemela
1Department of Medical Microbiology, University of Oulu, Finland. jari.karhukorpi@oulu.fi
Abstract:
CD14 is a pattern recognition receptor on the membranes of monocytes and macrophages for several microbial products, of which lipopolysaccharide (LPS) is the best known. A shed form of CD14 is present in serum. As the CD14 gene promoter polymorphism -159C/T and some bacterial infections may affect the sCD14 levels, we compared the impact of both the CD14 promoter polymorphism and Helicobacter pylori infection on serum sCD14 levels in 201 dyspeptic patients (group 1) who had undergone gastroscopy, and 127 staff members (group 2) with no endoscopy. sCD14 was measured from the sera by a commercial enzyme immunoassay (EIA), and CD14 genotyping was carried out with PCR. Helicobacter pylori infection was detected by serology and/or culture or PCR. sCD14 levels were elevated in the subjects carrying the T allele (CT or TT genotype) in both groups when compared with subjects with the CC genotype. Overall, H. pylori-positive subjects tended to have higher sCD14 levels compared with H. pylori-negative subjects. In group 1 consisting of dyspeptic patients, those with gastric ulcer, gastric erosion or duodenal ulcer had significantly elevated levels of sCD14 compared with the patients with normal endoscopic findings or macroscopic gastritis. The recent use of NSAIDs was also associated with enhanced sCD14. Thus, we were able to show several factors, one genetic and the other environmental (H. pylori infection and mucosal lesion), to have an impact on sCD14.
Insights
Serum soluble CD14 (sCD14) levels are influenced by genetic variations in the CD14 gene promoter and Helicobacter pylori infection. Both factors, along with gastric mucosal lesions, contribute to elevated sCD14 levels.
Area of Science:
- Immunology
- Genetics
- Gastroenterology
Background:
- CD14 is a key pattern recognition receptor involved in innate immunity.
- Soluble CD14 (sCD14) circulates in serum and its levels can be affected by genetic and environmental factors.
- Lipopolysaccharide (LPS) is a well-known ligand for CD14.
Purpose of the Study:
- To investigate the impact of CD14 gene promoter polymorphism (-159C/T) and Helicobacter pylori infection on serum sCD14 levels.
- To compare sCD14 levels in dyspeptic patients and healthy controls.
- To identify other factors influencing sCD14 levels in dyspeptic patients.
Main Methods:
- Serum sCD14 levels were measured using enzyme immunoassay (EIA).
- CD14 genotyping was performed using PCR.
- Helicobacter pylori infection was detected via serology, culture, or PCR.
- Patient groups included dyspeptic individuals undergoing gastroscopy and healthy staff members.
Main Results:
- Subjects with the T allele (CT or TT genotype) of the CD14 promoter polymorphism had elevated sCD14 levels compared to CC genotype.
- H. pylori-positive individuals showed a trend towards higher sCD14 levels.
- Dyspeptic patients with gastric ulcers, erosions, or duodenal ulcers had significantly higher sCD14 than those with normal findings or gastritis.
- NSAID use was also associated with increased sCD14.
Conclusions:
- Both genetic factors (CD14 promoter polymorphism) and environmental factors (H. pylori infection, mucosal lesions) significantly impact serum sCD14 levels.
- sCD14 may serve as a potential biomarker for certain gastrointestinal conditions and infections.
- Further research is warranted to explore the clinical implications of these findings.
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
